Oxford Biomedica (uk) Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Oxford Biomedica (uk) Limited

Patent Number:
Title:
Trophoblast Glycoprotein (5T4, Tpbg) Specific Chimeric Antigen Receptors For Cancer Immunotherapy
Applicant:
Opposition Date:
Sep 24, 2020
Patent Number:
Title:
Scalable Lentiviral Vector Production System Compatible With Industrial Pharmaceutical Applications
Applicant:
Opposition Date:
Oct 4, 2018

Competitors of Oxford Biomedica (uk) Limited

CELLECTIS

GENETHON

Want to track Oxford Biomedica (uk) Limited?

Feel free to send us a message here and we will get back to you